BIO Company Financials

BIO 
$114.05
*  
1.52
  negative  
1.32%
Get BIO Alerts
*Delayed - data as of May 24, 2013 10:34 ET 
Exchange: NYSE
Industry: Capital Goods
Community Rating:
View:    BIO Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$2,069,235 $2,073,529 $1,927,118 $1,784,244
Cost of Revenue
$915,097 $895,640 $835,630 $784,401
Gross Profit
$1,154,138 $1,177,889 $1,091,488 $999,843
Operating Expenses
Research and Development
$214,040 $186,439 $172,266 $163,585
Sales, General and Admin.
$682,898 $696,294 $635,213 $601,468
Non-Recurring Items
$0 $0 $0 $3,802
Other Operating Items
$0 $0 $0 $0
Operating Income
$257,200 $295,156 $284,009 $230,988
Add'l income/expense items
$16,843 ($6,259) ($9) $1,868
Earnings Before Interest and Tax
$274,043 $288,897 $284,000 $232,856
Interest Expense
$51,112 $53,135 $63,717 $47,024
Earnings Before Tax
$222,931 $235,762 $220,283 $185,832
Income Tax
$59,084 $57,739 $33,348 $36,667
Minority Interest
($69) $200 ($1,445) ($4,545)
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
$163,778 $178,223 $185,490 $144,620
Net Income
$163,778 $178,223 $185,490 $144,620
Net Income Applicable to Common Shareholders
$163,778 $178,223 $185,490 $144,620

See also: Company Financials data entry page